Today: 10 April 2026
Intuitive Surgical stock jumps on heavy volume as ISRG nears 52-week high ahead of key January dates
7 January 2026
1 min read

Intuitive Surgical stock jumps on heavy volume as ISRG nears 52-week high ahead of key January dates

New York, January 6, 2026, 21:40 EST — Market closed

  • Intuitive Surgical shares closed up 4.7% on Tuesday, extending a two-day rise
  • Focus turns to the company’s Jan. 14 conference presentation and Jan. 22 quarterly call
  • Traders watch Wednesday’s U.S. data for interest-rate cues that can sway growth stocks

Intuitive Surgical (ISRG) shares rose 4.7% on Tuesday to close at $592.85, outpacing several large-cap medical device peers as U.S. stocks advanced broadly. MarketWatch

The gain left the surgical-robot maker about 3.8% below its 52-week high of $616, a level some investors view as a near-term marker after the stock’s sharp run since early January. MarketWatch

That matters now because Intuitive is entering a stretch when management commentary can reset expectations, with investors looking for early signals on demand and margins before the next earnings update. Intuitive+1

Tuesday’s session was active. ISRG traded about 2.6 million shares, above its 50-day average of 1.8 million, and swung between roughly $564 and $595, market data showed. MarketWatch

Intuitive is scheduled to present at the 44th Annual J.P. Morgan Healthcare Conference on Jan. 14. It has also listed a fourth-quarter 2025 earnings conference call for Jan. 22 at 1:30 p.m. PST (4:30 p.m. ET). Intuitive+1

Investors will be listening for updates on procedure growth, hospital capital spending and gross margin — the share of revenue left after production costs — after the company previously raised its 2025 adjusted gross margin forecast in its October results. Reuters

Still, the setup cuts both ways. Intuitive trades at a premium to many medtech peers, and any sign of slower procedure growth, pricing pressure, or higher costs could sharpen the stock’s swings into results. MarketWatch

Before the next session, traders also face a slate of U.S. releases on Wednesday including ADP employment, the ISM services index and the JOLTS job openings report, all of which can move rate expectations and high-multiple stocks. The next company checkpoints are Jan. 14 and Jan. 22. Intuitive+3MarketWatch+3Bureau of Labor St…

Stock Market Today

  • Asia-Pacific Markets Mixed as Middle East Ceasefire Holds Tenuously
    April 9, 2026, 9:25 PM EDT. Asia-Pacific markets opened mixed Friday amid fragile U.S.-Iran ceasefire tension. South Korea's Kospi advanced 1.68%, Japan's Nikkei 225 rose 1.65%, while Australia's S&P/ASX 200 declined 0.51%. The ongoing Middle East conflict has disrupted the Strait of Hormuz, a vital energy passageway, keeping oil prices elevated with Brent crude near $96 and West Texas Intermediate above $98 per barrel. Japan plans to release 20 days of oil reserves starting May to cushion supply risk. U.S. markets saw gains with the S&P 500 up 0.62% as geopolitical risks kept investors cautious. Ceasefire conditions remain fragile as both sides finger violations, prolonging uncertainty in energy and stock markets globally.

Latest article

MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

MARA Holdings Stock Rises Even After Target Cut as Bitcoin Miner Leans Harder Into AI

9 April 2026
MARA Holdings shares rose 1.7% to $9.67 Thursday despite Cantor Fitzgerald cutting its price target to $10. The company recently sold 15,133 bitcoin for $1.1 billion and agreed to repurchase $1 billion in convertible notes at a discount. MARA is expanding into AI and cloud infrastructure, but fourth-quarter revenue fell 6% and it posted a $1.7 billion net loss.
CoreWeave secures fresh $21 billion Meta AI deal as debt push raises stakes

CoreWeave secures fresh $21 billion Meta AI deal as debt push raises stakes

9 April 2026
Meta Platforms signed a new $21 billion deal with CoreWeave for AI cloud computing capacity through 2032, according to a securities filing. CoreWeave shares rose 3.4% in after-hours trading. The agreement adds to a $14.2 billion commitment disclosed last September. CoreWeave also launched $3 billion in convertible notes and upsized a senior-notes deal to $1.75 billion.
Tesla Revives Cheaper EV Push With New Compact SUV as Sales Pressure Builds

Tesla Revives Cheaper EV Push With New Compact SUV as Sales Pressure Builds

9 April 2026
Tesla is developing a lower-cost compact SUV, with initial production planned for Shanghai, Reuters reported Thursday. The company built 408,386 vehicles and delivered 358,023 in the first quarter, leaving its widest gap in at least four years. Reuters said the new SUV likely will not reach production this year. Tesla did not respond to questions about the project.
NIO ES9 Price Starts at 528,000 Yuan as Flagship SUV Bet Faces China EV Slump

NIO ES9 Price Starts at 528,000 Yuan as Flagship SUV Bet Faces China EV Slump

9 April 2026
NIO opened pre-orders for its ES9 flagship SUV Thursday, pricing it at 528,000 yuan with battery or 420,000 yuan under its Battery-as-a-Service plan. March deliveries rose 136% year-on-year, but NIO’s U.S. shares fell 4.9% after the announcement. The ES9 enters a shrinking premium SUV market in China, competing with Li Auto and Aito. CEO William Li warned chip shortages could add up to 10,000 yuan per vehicle.
Plug Power Stock Climbs After 2026 Profit Push, Up to $200M Cost-Cut Plan

Plug Power Stock Climbs After 2026 Profit Push, Up to $200M Cost-Cut Plan

9 April 2026
Plug Power shares rose 2.5% to $2.715 Thursday after the company reaffirmed its target of positive EBITDAS by end-2026 and projected up to $200 million in savings from Project Quantum Leap. The update followed a major electrolyzer project win in Quebec and investor meetings in Toronto and Montreal. Plug reported 2025 revenue of $710 million and a fourth-quarter gross profit of $5.5 million.
Nike stock closes above $65 as sneaker-demand debate flares and jobs data looms
Previous Story

Nike stock closes above $65 as sneaker-demand debate flares and jobs data looms

Johnson & Johnson stock in focus after Tecvayli-Darzalex filing, lupus drug data
Next Story

Johnson & Johnson stock in focus after Tecvayli-Darzalex filing, lupus drug data

Go toTop